Initial injectable therapy in type 2 diabetes: Key considerations when choosing between glucagon-like peptide 1 receptor agonists and insulin
- Resource Type
- Review Article
- Source
- In
Metabolism September 2019 98:104-111 - Subject
- Language
- ISSN
- 0026-0495